April 7, 2026

Baylis Launches PowerWire 14 RF Guidewire to Treat Arterial and Venous Occlusions

April 7, 2026—Baylis Medical Technologies Inc. announced FDA 510(k) clearance and the commercial launch of the company’s PowerWire 14 radiofrequency (RF) guidewire, which is intended for use in both arterial and venous occlusions.

According to Baylis, the device is designed to facilitate the crossing of completely occluded native or stented peripheral vessels ≥ 3 mm in diameter. The 0.014-inch RF-enabled crossing wire provides physicians with a smaller-profile option when navigating challenging occlusions, stated the company.

The company explained that when the energized tip of the PowerWire 14 RF guidewire contacts metal, RF delivery automatically terminates, helping support controlled advancement during in-stent crossing while assisting physicians in managing challenging in-stent occlusions.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

April 7, 2026

Baylis Launches PowerWire 14 RF Guidewire to Treat Arterial and Venous Occlusions

Current Issue

Keep In Touch